Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Tricida

This Biotech Lost 95% in a Single Day. It Still Deserves Credit

Tricida only pursued a single drug candidate. That backfired spectacularly, but the drug developer deserves credit on one key measure.

Benzinga's Top Ratings Upgrades, Downgrades For October 25, 2022

Benzinga's Top Ratings Upgrades, Downgrades For October 25, 2022

Coinbase Global And 3 Other Stocks Insiders Are Buying

Coinbase Global And 3 Other Stocks Insiders Are Buying

Although US stocks closed lower on Thursday, there were a few notable insider trades.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

15 Biotech Stocks That Hit Year Highs Over The Last Week, Including Sarepta, Axsome

In recent days, biotech stocks have slowed their early-August sprint. But not all shares are ready to hit the showers.

Investors Business Daily

Insiders Buy More Than $15M Of 3 Stocks

Although the Dow Jones dropped by more than 600 points on Thursday, there were a few notable insider trades.

Analyst Ratings for Tricida

Within the last quarter, Tricida (NASDAQ:TCDA) has observed the following analyst ratings:

Read Why Did Tricida Stop VALOR-CKD Renal Outcomes Trial Early

Tricida Inc (NASDAQ:TCDA) said that, as anticipated, it is stopping its VALOR-CKD renal outcomes trial early for administrative reasons under the existing study protocol to allow for six months of financial runway following topline results, currently anticipated in early Q4 2022. VALOR-CKD trial, initiated in 2018, was designed to evaluate veverimer's ability to…

inkl

Read news from The Economist, FT, and more,
with one subscription

Tricida: Q1 Earnings Insights

Tricida: Q1 Earnings Insights

Tricida (NASDAQ:TCDA) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Tricida beat estimated earnings by 42.86%, reporting an EPS of $-0.4 versus an estimate of $-0.7.

Tricida's Earnings: A Preview

Tricida's Earnings: A Preview

Tricida (NASDAQ:TCDA) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Tricida will report an earnings per share (EPS) of $-0.70.

Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2022

Earnings Preview: Tricida

Earnings Preview: Tricida

Tricida (NASDAQ:TCDA) is set to give its latest quarterly earnings report on Tuesday, 2022-03-29. Here's what investors need to know before the announcement. Analysts estimate that Tricida will report an earnings per share (EPS) of $-0.68.

Tricida Flags Delay In Kidney Disease Trial Data Amid Russia-Ukraine Tension

Tricida Flags Delay In Kidney Disease Trial Data Amid Russia-Ukraine Tension

Tricida Inc (NASDAQ: TCDA) updated on the anticipated date for topline data from the VALOR-CKD trial based on the ongoing events in Ukraine.

The Daily Biotech Pulse: NuCana Shelves Biliary Tract Cancer Study, Tricida Data Readout Pushed Back Due to Ukrainian Crisis, Synlogic Names New CFO

The Daily Biotech Pulse: NuCana Shelves Biliary Tract Cancer Study, Tricida Data Readout Pushed Back Due to Ukrainian Crisis, Synlogic Names New CFO

Here's a roundup of top developments in the biotech space over the last 24 hours:

1

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Arista Networks

Intuitive Surgical

B of A Securities

Coinbase Global

Apollo Global Management

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play